Thermo Fisher Scientific Inc. [TMO] stock is trading at $550.78, down -1.32%. An important factor to consider is whether the stock is rising or falling in short-term value. The TMO shares have lost -1.15% over the last week, with a monthly amount drifted -3.81%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
On January 24, 2024, downgrade downgraded it’s rating to Equal Weight and revised its price target to $555 on the stock. Bernstein downgraded its rating to a Mkt Perform. HSBC Securities initiated its recommendation with a Buy and recommended $610 as its price target on December 18, 2023. Wolfe Research started tracking with a Outperform rating for this stock on December 13, 2023, and assigned it a price target of $575. In a note dated October 26, 2023, KeyBanc Capital Markets downgraded an Sector Weight rating on this stock.
Thermo Fisher Scientific Inc. [TMO] stock has fluctuated between $415.60 and $603.82 over the past year. Currently, Wall Street analysts expect the stock to reach $640 within the next 12 months. Thermo Fisher Scientific Inc. [NYSE: TMO] shares were valued at $550.78 at the most recent close of the market. An investor can expect a potential return of 16.2% based on the average TMO price forecast.
Analyzing the TMO fundamentals
Thermo Fisher Scientific Inc. [NYSE:TMO] reported sales of 42.49B for the trailing twelve months, which represents a drop of -3.41%. Gross Profit Margin for this corporation currently stands at 0.41% with Operating Profit Margin at 0.17%, Pretax Profit Margin comes in at 0.15%, and Net Profit Margin reading is 0.14%. To continue investigating profitability, this company’s Return on Assets is posted at 0.06, Equity is 0.13 and Total Capital is 0.08. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.78.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 547.25 points at the first support level, and at 543.73 for the second support level. However, for the 1st resistance point, the stock is sitting at 556.28, and for the 2nd resistance point, it is at 561.79.
Ratios To Look Out For
For context, Thermo Fisher Scientific Inc.’s Current Ratio is 1.70. On the other hand, the Quick Ratio is 1.33, and the Cash Ratio is 0.4. Considering the valuation of this stock, the price to sales ratio is 4.95, the price to book ratio is 4.62 and price to earnings (TTM) ratio is 35.34.
Transactions by insiders
Recent insider trading involved CASPER MARC N, Chairman & CEO, that happened on Jun 04 ’24 when 10000.0 shares were sold. Chairman & CEO, CASPER MARC N completed a deal on Jun 03 ’24 to sell 10000.0 shares. Meanwhile, Executive Vice President & COO Lagarde Michel sold 20000.0 shares on May 14 ’24.
